EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HIF-1α-ASS1 axis drives reprogramming of arginine metabolism controls hepatic stellate cell activation in hepatic fibrosis

Seungeun Lee, Yeonhwa Song, Sanghwa Kim, Quentin Leprat, Inhee Choi, Ji-Hee Kim, Yoon-Jin Lee, Haeng Ran Seo

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2026.158772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Seungeun Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Biomedical Research Lab, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488, Republic of…. Hauptthemen laut MEDLINE: Arginine, Hepatic Stellate Cells, Hypoxia-Inducible Factor 1, alpha Subunit, Liver Cirrhosis. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Commercializations Promotion Agency for R&D Outcomes, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated arginine metabolism promotes hepatic stellate cell (HSC) activation and liver fibrosis. However, the mechanisms underlying arginine hosmeostasis in hepatic fibrogenesis and therapeutic targeting remain unclear. Using Multicellular hepatic spheroid (MCHS) models recapitulating in vivo liver fibrosis, we investigated the effects of arginine deprivation or supplementation. Genetic and pharmacological (ABRL8301, a 2-methoxyestradiol derivative) inhibition of hypoxia-inducible factor 1 alpha (HIF-1α) were assessed for effects on argininosuccinate synthetase 1 (ASS1) expression and antifibrotic efficacy in vitro and in vivo. Holotomography and quantitative imaging approaches characterized cellular and molecular fibrogenic changes. Arginine deprivation increased MCHS compactness and α-smooth muscle actin (α-SMA) expression, whereas l-arginine supplementation reversed effects. Considering pivotal roles of ASS1 and arginase 1 (Arg1) in arginine biosynthesis and catabolism, respectively, ASS1 overexpression suppressed mesenchymal markers, whereas Arg1 overexpression aggravated fibrotic signatures. HIF-1α knockdown and ABRL8301 treatment upregulated ASS1, reduced epithelial-mesenchymal transition (EMT) and fibrotic markers, and enhanced arginine biosynthesis in MCHSs. Holotomography analysis confirmed ABRL8301 attenuated TGFβ1-induced cell elongation and α-SMA fiber accumulation in HSCs and fibroblasts. In CCl₄-mouse liver fibrosis models, ABRL8301 significantly reduced collagen deposition, necrosis, and fibrosis. Combination sorafenib and ABRL8301 therapy decreased MCHS compactness, increased apoptosis, and achieved superior tumor control in HCC xenografts. Restoring arginine metabolic homeostasis through HIF-1α inhibition-mediated ASS1 upregulation suppresses HSC activation and liver fibrosis. ABRL8301 acts as a pharmacologic inducer of ASS1 and arginine biosynthesis, inhibiting EMT and fibrotic progression while enhancing anticancer therapy. These findings support ABRL8301 as a promising antifibrotic and tumor-sensitizing agent in hepatic fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArginineHepatic Stellate CellsHypoxia-Inducible Factor 1, alpha SubunitLiver CirrhosisArgininosuccinate SynthaseAnimalsHumansArginaseMice2-MethoxyestradiolMaleMice, Inbred C57BLActins

Stichwörter der Autor:innen

Arginine metabolismArgininosuccinate synthetase 1 (ASS1)Hepatic fibrosisHypoxia-inducible factor 1 alpha (HIF-1α)Multicellular hepatic spheroid (MCHS)

Substanzen

ArginineHypoxia-Inducible Factor 1, alpha SubunitArgininosuccinate SynthaseArginase2-MethoxyestradiolActins

Autor:innen und Institutionen

  • Advanced Biomedical Research Lab, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488, Republic of Korea; Department of Advanced Drug discovery & development, Institut…
  • Advanced Biomedical Research Lab, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488, Republic of Korea.
  • AI Drug Discovery, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488, Republic of Korea.
  • Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, 75 nowongu nowon gil, Seoul, 01812, Republic of Korea.

Förderung

  • Commercializations Promotion Agency for R&D Outcomes
  • National Research Foundation of Korea

Zitieren

APA

Lee, S., Song, Y., Kim, S., Leprat, Q., Choi, I., Kim, J. H., Lee, Y. J., & Seo, H. R. (2026). HIF-1α-ASS1 axis drives reprogramming of arginine metabolism controls hepatic stellate cell activation in hepatic fibrosis. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158772

Vancouver

Lee S, Song Y, Kim S, Leprat Q, Choi I, Kim JH, et al. HIF-1α-ASS1 axis drives reprogramming of arginine metabolism controls hepatic stellate cell activation in hepatic fibrosis. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158772

BibTeX
@article{Lee2026,
  author = {Lee, Seungeun and Song, Yeonhwa and Kim, Sanghwa and Leprat, Quentin and Choi, Inhee and Kim, Ji-Hee and Lee, Yoon-Jin and Seo, Haeng Ran},
  title = {HIF-1α-ASS1 axis drives reprogramming of arginine metabolism controls hepatic stellate cell activation in hepatic fibrosis},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2026.158772}
}
Kostenlos starten →